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Implications Statement: 
 
We demonstrate that nitrous oxide (N2O) increases the incidence of postoperative 
nausea after laparoscopic gynecologic surgery. The preliminary findings indicate that N2O may 
increase PONV in dose dependant fashion. High concentration of N2O in this clinical setting is 
not recommended. 
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Abstract: 
 
Background: Whether nitrous oxide (N2O) increases incidence of postoperative nausea and 
vomiting (PONV) after laparoscopic gynecologic surgery is still controversial. This uncertainty 
may be due to the administration of different concentrations of inspired N2O. We investigated 
if N2O results in a dose response increase in PONV. 
Methods: Patients undergoing gynecologic laparoscopic surgery were randomized to receive 
30% oxygen with air (G0, n=46), 50% N2O with oxygen (G50, n=46) and 70% N2O with 
oxygen (G70, n=45). A standardized general anesthetic was used with no PONV prophylaxis. 
Known risk factors for PONV were controlled. Metoclopramide was used as a rescue 
antiemetic. Incidence of nausea, vomiting, use of rescue antiemetic and pain VAS score were 
measured at 2 and 24 hours postoperatively. 
Results: Patient demographics were comparable and there were no differences among groups 
with regards to factors that may influence PONV. Incidence of PONV at 24 hours was 33% 
(15/46) in G0 versus 46% (21/46) in G50 versus 62% (28/45) in G70 (p=0.018). Subgroup 
analysis revealed a difference between G0 vs G70 (p=0.018), but no significant difference 
between G0 vs G50 and G50 vs G70. The incidence of nausea showed a similar difference 
(G0=26%, G50=35% and G70=56%; p=0.012), but the incidence of vomiting was not different 
between the groups, although there was a trend (G0=28%, G50=35% and G70=42%; p=0.377). 
Severity of nausea (measured by VAS 100 mm) was significantly increased with increasing 
N2O concentration (G0=10.9, G50=12.7 and G70=20.5; p=0.027). The worst VAS score during 
24 hours was used for the analysis. There was no difference in the use of a rescue antiemetic. 
Pain VAS scores and opioids consumption were not different among groups (at 2h and 24h 
after surgery). 
Conclusion: N2O increases the incidence of postoperative nausea after gynecologic 
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laparoscopic surgery. This preliminary findings indicate that N2O may increase PONV in dose 
dependent fashion. A study with sample size of > 400 patients in each group would  be 
necessary to demonstrate a statistically significant difference among each of these three groups. 
We do not recommend using high concentration of N2O in this clinical setting. 
 
Word Count: 342 
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Introduction: 
 
             Postoperative nausea and vomiting (PONV) are common complications after 
gynecologic laparoscopic surgery. In the absence of prophylactic antiemetics the incidence of 
PONV may be as high as 40% - 77% (1-4). The administration of prophylactic antiemetics, 
either alone or in combination have been shown to reduce this incidence. However, the routine 
administration of antiemetics increases costs and side effects (5,6). Reducing baseline risk has 
been recommended as an effective strategy for reducing PONV, including using specific 
anesthetic techniques that minimize the risk of PONV (7,8). 
 Nitrous oxide (N2O) has analgesic and sedative properties (9), but may potentially 
increase the incidence of PONV (10,11). N2O might increase incidence of PONV by several 
potential mechanisms: 1) increase in middle ear pressure (12,13); 2) bowel distension which is 
controversial (14-16). A recent meta-analysis revealed that each additional hour of anesthesia 
using N2O doubles the risk of bowel distension (odds ratio 2.09; 95% CI 1.27–3.59) compared 
with anesthesia using air/oxygen (14); 3) activation of the dopaminergic system in the 
chemoreceptor trigger zone (17); and 4) interaction with opioid receptors (18).  
The evidence on PONV after N2O/volatile anesthetic (enflurane or isoflurane) in 
gynecologic laparoscopic surgery is controversial. N2O has been demonstrated to increase the 
incidence of PONV in some studies (10,11,19-22) but not others (23-26). Most of the studies 
on the influence of N2O on PONV used 60% to 70% inspiratory concentration (FI) of N2O. It is 
not clear if limiting N2O to a lower concentration decreases the risk of PONV. We postulate 
that inspiratory concentration of N2O has a dose/response relationship to the incidence of 
PONV. Our experimental hypothesis is that the incidence of PONV would increase as 
inspiratory N2O concentration increases from 50% and 70% when compared to air/oxygen (FI 
O2 30%) as a control group in gynecologic laparoscopic surgery under general anesthesia. 
 8 
Methods: 
 
After Institutional Review Board approval, written informed consent was obtained in 
150 ASA PS I and II patients, between 19 to 75 years old, undergoing elective laparoscopic 
gynecological surgery (removal of the ovarian tumors and cysts, myomectomy, laparoscopic 
assisted vaginal hysterectomy and infertility surgery). The exclusion criteria were obesity (BMI 
>33 kg/m²), pregnancy, breast feeding, known hypersensitivity to drugs used in the study 
protocol, use of antiemetics, psychotropic drugs and steroids within 72 h before surgery. 
Patients with known comorbidities that may increase the incidence of PONV were also 
excluded, i.e. diseases which impaired gastric motility (diabetes mellitus, chronic cholecystitis, 
gastric and intestinal disease, neuromuscular disorders, neuropathies and liver dysfunction), 
vestibular disease, history of migraine headache, central nervous system injury, renal 
impairment, irregular menstrual cycle (duration of <21 or >35 days and/or variations between 
cycles >4 days), alcoholism and opioid addiction. 
As per standard practice in the hospital, patients received 7.5 mg of midazolam PO 1 h 
before the surgery with no prophylactic antiemetics. Standard monitoring was applied 
including electrocardiography, noninvasive blood pressure, pulse oximetry and capnography. 
After induction of anesthesia with thiopental 5 mg/kg and fentanyl 1-2 µg/kg, patients 
were manually ventilated via face mask with oxygen. Endotracheal intubation was facilitated 
with vecuronium 0.1 mg/kg IV. Patients were randomized by computer-generated random 
numbers to receive air and oxygen, FI O2 30% (group G0), 50% N2O and oxygen (group G50) 
or 70% N2O and oxygen (group G70). Anesthesia was maintained with sevoflurane (end tidal 
concentration ~1 minimum alveolar concentration [MAC]) and supplemental bolus doses of 
fentanyl IV (1 µg/kg) to keep heart rate and blood pressure within 20% of baseline values and 
additional vecuronium was administered to maintain a one or two twitches on the train-of-four 
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monitor. All patients received 10 ml/kg of crystalloids intraoperatively. Insertion of a 
nasogastric tube and gastric suction was not used. Neuromuscular blockade was antagonized 
with neostigmine 2.5 mg and atropine 1 mg IV. 
Postoperatively, patients received 1000 ml (5 ml/kg/h) of crystalloids. The incidence of 
postoperative nausea, vomiting and the use of rescue antiemetic were collected at 2 and 24 
hours after surgery. Severity of postoperative nausea and pain were evaluated using a 100 mm 
visual analogue scale (VAS) during the first 24 hours postoperatively (VAS 0 = no 
pain/nausea, 100 = maximal pain/nausea). A nausea VAS score was measured for each episode, 
but the worst score during the early and the late period was used for statistical evaluation. 
Patients who experienced at least one episode of nausea, vomiting or retching or any 
combination of these occurred during 24 hours postoperatively were considered to have had 
PONV . POV was defined as at least one episode of vomiting or retching that occurred within 
24 hours postoperatively. PONV was defined as early (within first 2 hours) or late (2 to 24 
hours postop). Clinical nurses specifically trained for the study collected the data and were 
blinded to the anesthesia technique used and randomization. Pain VAS score and total amount 
of opioids were recorded at 2 hours and at 24 hours postoperatively. Metoclopramide 10 mg IV 
was used as the rescue antiemetic. This was the standard clinical practice in the hospital. The 
administration of rescue antiemetic was based on the following criteria: patients who had two 
or more episodes of vomiting or retching within a period of 30 min, nausea lasting more than 
15 min or  nausea VAS score 50 mm or greater, or when a patient requested treatment. 
Diclofenac 75 mg IM was given immediately after surgery and if needed 12 hours later. For 
severe pain (VAS >40 mm) meperidine 25 mg up to 100 mg IV was used. All patients 
remained in the hospital for at least for 24 hours, as was our standard practice for laparoscopic 
gynecological surgery.  
Statistical analysis 
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Calculation of sample size was based on preliminary data collected at General Hospital Zadar, 
Zadar, Croatia (27). A total of 45 patients per group would be sufficient to demonstrate a 
reduction of PONV by 20% from G70 to G50 and by 20% from G50 to G0 with a power of 0.8 
and α < 0.05. The expected incidence of PONV at 24 hours was for G0=30%, G50=50% and 
G70=70%. The data were analyzed using statistical program SAS 8.2. Quantitative values were 
compared using Kruskal-Wallis test and Mann-Whitney U test with correction for multiple 
comparisons between the groups. Categorical data were analyzed by Pearson Chi-Square test 
or Fisher's exact test with correction for multiple comparisons as appropriate. Data were 
expressed as number or percentages and mean±SD. A p value of < 0.05 was considered 
statistically significant. 
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Results: 
 
One hundred thirty seven of 150 patients completed the study (G0=46, G50=46, 
G70=45). A total of 13 patients were excluded from the analysis. Four patients were excluded 
in G0: one patient was treated with corticosteroids for urticaria at induction of anesthesia, one 
patient had an anesthesia time less than 30 min, 2 patients had a protocol violation; 4 patients 
were excluded in G50: conversion to laparotomy, anesthesia time less than 30 min and 2 
patients had a protocol violation; 5 patients were excluded in G70: 2 patients’ surgery was 
converted to laparotomy, 1 patient each had severe hypotension after induction which lasted 
more than 5 minutes, acute coronary syndrome postoperatively and anesthesia time less than 30 
min. 
There was no difference among groups regarding age, weight, height, BMI, ASA 
physical status, smoking status, history of motion sickness and/or PONV, phase of menstrual 
cycle, thiopental dose, duration of anesthesia and surgery and type of surgery (Table 1), 
There was an overall difference in the incidence of PONV for 24 hours after surgery 
between the groups (p=0.018) (Table 2). G0 was significantly different vs G70 (p=0.018) but 
no difference was noted between G0 vs G50 (p=0.855) or G50 vs G70 (p=0.426) (Table 2). 
Although there was a trend towards an increase in the incidence of early PONV (two hours 
postoperatively) and late postoperative period (2-24h) with increasing N2O concentration this 
did not reach statistical significance, p=0.071 and p=0.437, respectively (Table 2). The 
incidence of nausea showed a similar significant difference, with p=0.012, but the incidence of 
vomiting was no different between the groups, although there was a trend (Table 2). The 
severity of nausea was significantly increased with increasing N2O concentration. There was no 
difference in the need for rescue antiemetic (Table 2), pain scores or opioids consumption 
between the groups (at 2h and 24h after surgery) (Table 3). 
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Discussion: 
 
This study demonstrates that N2O when administered with oxygen and sevoflurane 
increases the incidence of postoperative nausea. The preliminary findings indicate that N2O 
may increase PONV in dose/respose fashion. The inspired concentration of 70% N2O 
significantly increases the incidence of PONV at 24 hours, nausea at 24 hours and nausea VAS 
scores when compared with no N2O. In contrast, inspired concentration of 50% N2O did not 
show significant increased PONV, nor nausea at 24 hours compared with patients who received 
only oxygen/air. 
We chose 50% and 70% N2O in this study because of their clinical relevance. Inspired 
concentrations of N2O lower than 50% are rarely used in anesthesia practice. The inspired 
concentration of 50% N2O was chosen because it is generally perceived by anesthesiologists 
that this concentration has minimal effect in increasing the incidence of PONV (28). However, 
there is no data to support that assumption. 70% N2O was selected as it represents the highest 
concentration of N2O used in clinical anesthesia practice. 
All the reported studies on PONV after N2O/volatile anesthetic (enflurane or isoflurane) 
in gynecologic laparoscopic surgery compared a single inspired concentration of N2O, usually 
in the range of 66%-70%, with control (20,21,23,24). The results from this study agrees with 
Felts et al. who demonstrated that PONV is increased from 9.3% in air/oxygen (FI O2 33%) to 
29.2% with 66% of N2O in oxygen following enflurane anesthesia for outpatient gynecologic 
laparoscopy (p<0.001) (21). Contrary to our study, Hovorka et al. did not find significant 
differences in the incidence of PONV among three groups of patients anesthetized with either 
isoflurane or enflurane with 70% N2O in oxygen, and isoflurane without N2O, following 
gynecological laparoscopy (23). This discrepancy could be explained by the different duration 
of the anesthesia (the mean anesthesia times among groups were 37 to 40 minutes in Hovorka’s 
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study and 70 to 76 minutes in our study). One of the mechanisms of N2O induced nausea and 
vomiting might be related to the middle ear pressure. The longer duration of N2O exposure, as 
in our study, likely caused a larger increase in middle ear pressure as the time to reach peak 
middle ear pressure is about 60 min following the introduction of N2O and about 30 minutes to 
return to baseline after N2O is discontinued (12). Also, in Hovorka’s study smoking status was 
unknown which could bias the results. 
Lonie et al. found significant increase only in the incidence of vomiting (from 17% 
without N2O to 49% with N2O 67% in oxygen following enflurane anesthesia), but not nausea 
between groups (20). This could be due to the more frequent administration of rescue 
antiemetic in our study. We treated the patients with severe nausea as well as patients who 
vomited (22% of patients in the both groups with N2O and 15% in the group without N2O). 
However, only a few patients were treated in Lonie’s study (7.5% patients in N2O group and 
7.1% in the group without N2O). Sengupta et al. reported similar results as Lonie and 
colleagues, but the study was underpowered, with a smaller number of patients (total 64) and 
resulted in a non statistical difference between N2O group and oxygen group, 33% vs 12.9%, 
respectively (24).  
Recent results from the IMPACT study suggest that omitting N2O in a multimodal 
PONV prophylaxis strategy further decrease the incidence of PONV by about 12%, if volatile 
anesthetic is used (29). However, the study did not address the dose response relationship of 
N2O. The preliminary results from our study which showed that 70% N2O increases the 
incidence of nausea concur with IMPACT study and a recent meta-analysis (10,29). Although 
our initial power analysis was expected to provide adequate power to demonstrate a dose 
response our actual results showed a smaller than expected difference. Assuming that this trend 
in the incidence of PONV at 24 hours were to persist, a study with sample size of 221 patients 
in each group would have been necessary to produce a statistically significant difference 
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among each of three groups with a power of 0.8 and α < 0.05. Using the same assumption it 
would require 410 patients per group to show the significant difference in the incidence of 
nausea at 24 hours, and 691 patients per group for the incidence of vomiting at 24 hours. The 
value of this study is that it provides preliminary data that indicate that N2O may increase 
PONV in a dose/response fashion. We feel it would be valuable that a large prospective study 
should be performed to confirm if 50% N2O has a lower incidence of PONV than 70% N2O. 
There are several limitations to our study. It can be criticized that we should have 
administered a prophylactic antiemetic or combination strategy given the high risk nature of 
this surgical population for PONV. We however wanted to specifically investigate the dose 
response effect of nitrous oxide which may have been masked by the use of prophylactic 
antiemetics. The difference in N2O concentrations between the groups also means that the FI 
O2 was different in G50 and G70. High FI O2 (0.8) has been shown to reduce the incidence of 
PONV (30,31). However, more recent studies have cast doubt on previous findings. Purhonen 
et al. in an ambulatory gynecological laparoscopic patients showed that supplemental oxygen 
does not reduce the incidence of postoperative nausea and vomiting (32). The authors 
compared FI O2 30% and FI O2 80% oxygen with additional O2 in PACU up to 1 hour but did 
not find difference in the PONV incidence after 24 hours, 62% vs 55%, respectively. Our study 
had only a 20% difference in FI O2 among the groups compared with 50% difference in 
Purhonen’s study and we did not use supplemental oxygen in PACU. Therefore, the impact of 
oxygen in our study is likely to be small, if any. Furthermore, a recent large study involving 
560 patients investigating the impact of oxygen on PONV concluded that oxygen has no impact 
of PONV irrespective of the site or surgery or the observational period (early or late PONV) 
(33). 
In conclusion, we demonstrate that 70% N2O increases the incidence of nausea and 
severity of nausea at 24 hours after laparoscopic gynecological surgery in the absence of any 
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prophylactic antiemetic. This preliminary findings indicate that N2O may increase PONV in 
dose dependent fashion. A study with sample size of > 400 patients in each group would be 
necessary to produce a statistically significant difference among groups with no N2O, 50% N2O 
and 70% N2O. We do not recommend using high concentration of N2O in this clinical setting. 
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Table 1. Patient Demographics.  
                                                           G0                              G50                                 G70           
                                                        (n=46)                          (n=46)                           (n=45) 
 
Age (yr)                                           35.8 ± 10.5                36.7 ± 11.9                    37.8 ± 14.1 
 
Weight (kg)                                      66.2 ± 9.1                 68.3 ± 10.5                    67.4 ± 10.6  
 
Height (cm)                                     169.9 ± 6.9                168.9 ± 5.0                    167.9 ± 5.7 
 
ASA physical status (I/II)                   36/10                        35/11                            35/10 
 
Smoking n (%)                                   20 (43%)                   17 (37%)                     18 (40%)  
 
History of motion sickness                16 (35%)                   23 (50%)                      16 (36%)    
and/or PONV n (%)  
 
Phase of menstrual cycle (n)         
   Follicular/Luteal                                   28 /14                       25/14                         23/12 
   Post-menopause                                       4                               7                               10 
 
Thiopental (mg)                                        331 ± 45               341 ± 52                 337 ± 53 
 
Duration of anesthesia (min)                   72.3 ± 36.1            76.3 ± 36.2             70.4 ± 31.9 
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Duration of surgery (min)                       54.6 ± 33.9            59.8 ± 34.8              53.3 ± 30.8 
 
Type of surgery (n)                      
   Ovarian cystectomy/ 
    tumorectomy                              29                             29                                 25 
   Myomectomy                               6                              7                                    6 
   Laparoscopic assisted  
   Vaginal hysterectomy                  3                              2                                    4 
   Laparoscopy for infertility           8                              8                                  10 
 
No statistical differences among groups (G0= air, G50=50% nitrous oxide, G70=70% nitrous 
oxide).  
Data presented as mean±SD or n (%). 
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Table 2. Incidence of PONV, nausea, vomiting and use of rescue antiemetic.  
 
                                          G0- air                    G50-50% N2O             G70-70% N2O       p value 
                                          (n=46)                           (n=46)                         (n=45) 
 
PONV (24h) (n, %)           15 (33%)                       21 (46%)                  28 (62%)†          0.018* 
PONV (0-2h) (n, %)          10 (22%)                      16 (35%)                   20 (44%)            0.071 
PONV (2-24h) (n, %)          9 (20%)                      11 (24%)                   14 (31%)            0.437 
 
Nausea (24h) (n, %)            12 (26%)                   16 (35%)                   25 (56%)†           0.012* 
Nausea (0-2h) (n, %)             9 (20%)                   12 ( 26%)                  19 (42%)             0.05 
Nausea (2-24h) (n, %)           6 (13%)                     8 (17%)                     9 (20%)             0.668 
Nausea VAS scores (mm)    10.9±20.5                 12.7±19.5                  20.5±21.8†         0.027* 
Severe nausea                        3 (7%)                       3 (7%)                       4 (9%)               0.882 
 
Vomiting (24h) (n, %)          13 (28%)                      16 (35%)                  19 (42%)           0.377 
Vomiting (0-2h) (n, %)          8 (17%)                      11 (24%)                   14 (31%)           0.31  
Vomiting (2-24h) (n, %)        8 (17%)                        9 (20%)                   12 (27%)           0.527 
Vomiting episodes                2.6 ±1.1                        2.7±2.3                      2.4±1.9             0.463 
in patients who vomited                           
Severe vomiting                     5 (11%)                        6(13%)                      6(13%)            0.926 
 
Metoclopramide (n, %)         7 (15%)                        10 (22%)                   10 (22%)          0.642   
 
 
 23 
Data presented as mean±SD. 
PONV - postoperative nausea and/or vomiting 
Severe nausea - VAS >50 mm or duration longer than 15 minutes 
Severe vomiting - 2 or more episodes of vomiting and retching within a period of 30 min or 
total number of three or more emetic episodes during 24 h postoperatively  
* Statistically significant difference (p< 0.05) 
† Statistically significant vs G0 (p< 0.05) 
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Table 3. Pain VAS score and opioid consumption. 
 
                                          G0                               G50                              G70                p value 
                                       (n=46)                          (n=46)                          (n=45) 
 
Pain VAS scores (mm) 
Postop at   2 h                 21.6±13.0                   25.4±12.9                   23.9±15.1            0.30 
  
                 24 h                16.8±8.5                     13.8±11.9                   12.6±12.3            0.06 
 
Intraoperative                   180±70                       190±60                        180±80              0.22 
fentanyl (mcg)                     
                            
Postoperative                    6.5±22.0                   7 .1±16.4                     10.1±19.6           0.27 
meperidine (mg)               
 
 
 
No statistical differences among groups (G0=air, G50=50% nitrous oxide, G70=70% nitrous 
oxide).  
Data presented as mean ± standard deviation. 
